ATE338558T1 - Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern - Google Patents

Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern

Info

Publication number
ATE338558T1
ATE338558T1 AT96924920T AT96924920T ATE338558T1 AT E338558 T1 ATE338558 T1 AT E338558T1 AT 96924920 T AT96924920 T AT 96924920T AT 96924920 T AT96924920 T AT 96924920T AT E338558 T1 ATE338558 T1 AT E338558T1
Authority
AT
Austria
Prior art keywords
pct
neurodegenerative diseases
phosphoglycero
phosphoglycerides
ether
Prior art date
Application number
AT96924920T
Other languages
English (en)
Inventor
Marcel Forgeot
Original Assignee
Inst Rech Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Rech Biolog Sa filed Critical Inst Rech Biolog Sa
Application granted granted Critical
Publication of ATE338558T1 publication Critical patent/ATE338558T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT96924920T 1995-07-07 1996-07-02 Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern ATE338558T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9508223A FR2736265B1 (fr) 1995-07-07 1995-07-07 Nouvelles compositions a base de phosphoglycero ethers et leur utilisation dans le traitement des maladies neuro-degeneratives

Publications (1)

Publication Number Publication Date
ATE338558T1 true ATE338558T1 (de) 2006-09-15

Family

ID=9480779

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96924920T ATE338558T1 (de) 1995-07-07 1996-07-02 Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern

Country Status (9)

Country Link
US (1) US5759585A (de)
EP (1) EP0781137B1 (de)
JP (1) JPH10505614A (de)
AT (1) ATE338558T1 (de)
AU (1) AU6521596A (de)
CA (1) CA2199289C (de)
DE (1) DE69636510D1 (de)
FR (1) FR2736265B1 (de)
WO (1) WO1997002828A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004026803A (ja) * 2002-03-29 2004-01-29 Nof Corp 神経細胞死予防剤
JP2006516262A (ja) * 2002-12-17 2006-06-29 ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド Ｙ２受容体結合ペプチドの粘膜送達促進のための組成物および方法ならびに肥満症の治療法および予防法
AU2007346587C1 (en) 2007-02-08 2015-01-22 Med-Life Discoveries Lp Methods for the treatment of Senile Dementia of the Alzheimer's Type
TWI475989B (zh) 2008-12-22 2015-03-11 Phenomenome Discoveries Inc 縮醛磷脂類化合物，含彼之醫藥組成物以及治療老化疾病的方法
EP2403491A2 (de) 2009-03-04 2012-01-11 Nestec S.A. Alkylglycerole und alkoxyglycerole zur erhöhung der endogenen plasmalogen-spiegel bei säugetieren
JP6016363B2 (ja) * 2010-01-06 2016-10-26 丸大食品株式会社 脳神経細胞新生剤
KR101787618B1 (ko) * 2010-09-24 2017-10-18 후지노 브레인 리서치 가부시키가이샤 항중추신경계 염증제
CA2812129C (en) * 2011-11-17 2014-10-21 Phenomenome Discoveries Inc. Methods for the synthesis of 13c labeled plasmalogen
JP6603923B2 (ja) * 2016-05-02 2019-11-13 有限会社梅田事務所 認知機能の改善作用を有する鶏胸肉由来プラズマローゲン組成物及びこれを含有して成る認知機能の向上及び／又は改善用食品組成物又はサプリメント
CN109153693B (zh) * 2016-05-02 2022-08-02 有限会社梅田事务所 安全－稳定的缩醛磷脂和其制剂及认知症的未病状态的判断方法
JP7309136B2 (ja) * 2017-04-14 2023-07-18 学校法人帝京大学 Ｈｄｌ機能改善剤及びｈｄｌ機能改善食品組成物
CN115768398B (zh) * 2020-06-30 2024-10-15 株式会社流变机能食品研究所 生发及/或育发用组合物
JP7894148B2 (ja) * 2021-03-12 2026-07-23 株式会社 レオロジー機能食品研究所 歯周組織炎症改善用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613621A (en) * 1981-09-18 1986-09-23 Hoerrmann Wilhelm Fatty aldehydes and acids in the treatment of neurological and inflammatory diseases
DE4133080A1 (de) * 1991-09-30 1993-04-01 Schering Ag Plasmalogenanaloga
IT1260149B (it) * 1992-04-17 1996-03-28 Fidia Spa Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
FR2721516B1 (fr) * 1994-06-27 1996-09-13 Inst Rech Biolog Sa Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation.

Also Published As

Publication number Publication date
DE69636510D1 (de) 2006-10-19
FR2736265A1 (fr) 1997-01-10
CA2199289A1 (fr) 1997-01-30
FR2736265B1 (fr) 1997-09-26
WO1997002828A1 (fr) 1997-01-30
EP0781137A1 (de) 1997-07-02
US5759585A (en) 1998-06-02
JPH10505614A (ja) 1998-06-02
EP0781137B1 (de) 2006-09-06
AU6521596A (en) 1997-02-10
CA2199289C (fr) 2011-09-13

Similar Documents

Publication Publication Date Title
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
ATE231134T1 (de) Verwendung von dioxomorpholinen zur bekämpfung von endoparasiten, neue dioxomorpholine und verfahren zu ihrer herstellung
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE69636510D1 (de) Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern
UA29505C2 (uk) Фармацевтична композиція для лікування і/або профілактики розрідження кістки і спосіб лікування і/або профілактики розрідження кістки у ссавців
DE69113848D1 (de) Verwendung von Phosphatidylglycerol(diC 18:10) zur Behandlung obstruktiver Atemwegserkrankungen.
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
DE69401577D1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
ATE232874T1 (de) Prostaglandin-konjugate zur behandlung von knochenkrankheiten
ATE35415T1 (de) Pharmazeutische zusammensetzungen und verfahren fuer die herstellung von zusammensetzungen mit gehalt an phosphatidylserine zur behandlung von stoerungen des centralen nervensystems ohne wirkungen auf die blutkoagulation.
ATE382061T1 (de) Mittel zur induktion von apoptosis und zur therapieanwendung
ATE157876T1 (de) Wirkstofffreie liposomen zur behandlung von atherosklerose
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE69811407D1 (de) Verwendung eines oberflächenaktiven mittels zur herstellung eines arzneimittels zur behandlung von erkrankungen des mittelohrs
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
EE200000163A (et) Protsess kirurgiliste instrumentide puhastamiseks
DE59508366D1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
DE69829995D1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
DE3865283D1 (de) Butylhydroxyanisole zur behandlung von retrovirus-krankheiten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties